NasdaqGS - Nasdaq Real Time Price USD

Assembly Biosciences, Inc. (ASMB)

13.60
+0.18
+(1.34%)
As of 1:50:39 PM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
32,154
28,520
7,163
0
6,254
Operating Expense
76,786
73,940
71,809
94,114
97,304
Operating Income
-44,632
-45,420
-64,646
-94,114
-91,050
Net Non Operating Interest Income Expense
5,044
5,573
3,451
1,022
302
Other Income Expense
5
--
--
--
-41,638
Pretax Income
-39,588
-39,847
-61,195
-93,092
-132,386
Tax Provision
--
330
33
0
-2,531
Net Income Common Stockholders
-39,918
-40,177
-61,228
-93,092
-129,855
Diluted NI Available to Com Stockholders
-39,918
-40,177
-61,228
-93,092
-129,855
Basic EPS
-6.20
--
-13.38
-23.04
-36.00
Diluted EPS
-6.20
--
-13.38
-23.04
-36.00
Basic Average Shares
6,510.31
--
4,577.37
4,034.11
3,606.70
Diluted Average Shares
6,510.31
--
4,577.37
4,034.11
3,606.70
Total Operating Income as Reported
-44,632
-45,420
-64,646
-94,114
-132,688
Total Expenses
76,786
73,940
71,809
94,114
97,304
Net Income from Continuing & Discontinued Operation
-39,918
-40,177
-61,228
-93,092
-129,855
Normalized Income
-39,918
-40,177
-61,228
-93,092
-89,008.12
Interest Income
5,044
5,573
3,451
1,022
302
Net Interest Income
5,044
5,573
3,451
1,022
302
EBIT
-44,632
-45,420
-64,646
-94,114
-91,050
EBITDA
-44,502
-45,291
-64,196
-93,616
-90,584
Reconciled Depreciation
130
129
450
498
466
Net Income from Continuing Operation Net Minority Interest
-39,918
-40,177
-61,228
-93,092
-129,855
Total Unusual Items Excluding Goodwill
--
--
--
0
-41,638
Total Unusual Items
--
--
--
0
-41,638
Normalized EBITDA
-44,502
-45,291
-64,196
-93,616
-48,946
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-791.12
12/31/2021 - 12/17/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers